Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
10,915,750
-
Total 13F shares
-
11,235,379
-
Share change
-
+328,482
-
Total reported value
-
$1,404,646,771
-
Put/Call ratio
-
91%
-
Price per share
-
$125.02
-
Number of holders
-
234
-
Value change
-
+$7,145,351
-
Number of buys
-
123
-
Number of sells
-
139
Institutional Holders of MEDIFAST INC - Common Stock, $0.001 par value per share (MED) as of Q4 2018
As of 31 Dec 2018,
MEDIFAST INC - Common Stock, $0.001 par value per share (MED) was held by
234 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,235,379 shares.
The largest 10 holders included
BlackRock Inc., Vanguard Group Inc, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, ACADIAN ASSET MANAGEMENT LLC, STATE STREET CORP, MERIAN GLOBAL INVESTORS (UK) Ltd, PRINCIPAL FINANCIAL GROUP INC, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, and Bank of New York Mellon Corp.
This page lists
235
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.